E
Pliant Therapeutics, Inc. PLRX
$1.48 $0.010.68% NASDAQ
Recommendation
Prev Close
$1.47
Volume
581,216
Avg Vol (90D)
2,074,873
Market Cap
$90.24M
Dividend & Yield
--
52-Week Range
$1.10 - $16.52
P/E (TTM)
--
EPS (TTM)
-$3.47
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Price T Rowe Associates Inc. MD Reduces Position in Pliant Therapeutics, Inc. (NASDAQ:PLRX)
4/29/2025 - Ticker Report
Pliant Therapeutics, Inc. (NASDAQ:PLRX) Given Consensus Rating of "Hold" by Brokerages
4/28/2025 - MarketBeat
Blue Owl Capital Holdings LP Has $36.47 Million Position in Pliant Therapeutics, Inc. (NASDAQ:PLRX)
4/26/2025 - MarketBeat
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pliant Therapeutics, Inc. PLRX
4/25/2025 - Globe Newswire
Silverarc Capital Management LLC Makes New Investment in Pliant Therapeutics, Inc. (NASDAQ:PLRX)
4/22/2025 - Ticker Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pliant Therapeutics, Inc. - PLRX
4/21/2025 - Globe Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pliant Therapeutics, Inc. - PLRX
4/21/2025 - Globe Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pliant Therapeutics, Inc. - PLRX
4/17/2025 - Globe Newswire
PLIANT THERAPT (PLRX) Upgraded to Buy: Here's What You Should Know
4/10/2025 - Zacks Investment Research
Pliant Therapeutics Announces Upcoming Presentations at the 2025 American Thoracic Society ...
4/7/2025 - GuruFocus
Pliant Therapeutics Announces Upcoming Presentations at the 2025 American Thoracic Society International Conference
4/7/2025 - Globe Newswire
Pliant Therapeutics, Inc. (NASDAQ:PLRX) Sees Significant Growth in Short Interest
4/4/2025 - MarketBeat
Pliant Therapeutics: An Activist On Deck
4/3/2025 - SeekingAlpha
Pliant Therapeutics: An Activist On Deck
4/3/2025 - Seeking Alpha - Long Ideas
Pliant Therapeutics, Inc. (NASDAQ:PLRX) Short Interest Update
4/3/2025 - Ticker Report
Pliant Therapeutics, Inc. (NASDAQ:PLRX) Given Consensus Rating of "Hold" by Brokerages
4/3/2025 - MarketBeat
concentra swoops revive struggling allakos softening blow other denied buyout attempts
4/2/2025 - FierceBiotech.com - Biotech
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Pliant Therapeutics
3/30/2025 - Globe Newswire
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Pliant Therapeutics
3/28/2025 - PR Newswire
PLRX Stock Plunges 89% in 3 Months: Here's What Investors Should Know
3/27/2025 - Zacks Investment Research
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Pliant Therapeutics PLRX
3/26/2025 - Globe Newswire
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Pliant Therapeutics
3/23/2025 - Globe Newswire
TANG CAPITAL MANAGEMENT LLC Acquires Significant Stake in Pliant Therapeutics Inc
3/21/2025 - GuruFocus
Pliant Therapeutics (NASDAQ:PLRX) Receives Neutral Rating from HC Wainwright
3/19/2025 - MarketBeat
Pliant Therapeutics announces interim Phase 1 data from PLN-101095
3/17/2025 - The Fly
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
-$226.24M
EBIT (TTM)
-$228.37M
Net Income (TTM)
-$210.30M
Balance Sheet
Total Assets (Q)
$396.95M
Total Debt (Q)
$60.19M
Total Liabilities (Q)
$92.87M
Book Value Per Share (Q)
$5.00
Cash Flow
Cash from Operations (TTM)
-$155.50M
Cash from Investing (TTM)
$140.34M
Cash from Financing (TTM)
$23.12M
Net Change in Cash (TTM)
$7.95M
Filings
Filing Date
Monday, March 3, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 5 and 9 (est)
Price History
Loading...
Beta
1.08
7-Day Total Return
1.37%
30-Day Total Return
-12.94%
60-Day Total Return
-86.23%
90-Day Total Return
-89.21%
Year to Date Total Return
-88.86%
1-Year Total Return
-87.76%
2-Year Total Return
-93.37%
3-Year Total Return
-74.74%
5-Year Total Return
--
52-week Low
Apr 09, 2025 - $1.10
52-week High
May 15, 2024 - $16.52
Valuation
Market Cap
$90.24M - Micro Cap
Enterprise Value
-$205.29M
Price/Sales (TTM)
--
Price/Book (Q)
0.29
Dividends and Shares
Shares Outstanding
60.85M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
pliantrx.com
Phone Number
650 481 6770
Address
331 Oyster Point Boulevard
South San Francisco, CA 94080
Country
United States
Year Founded
2015
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Pliant Therapeutics, Inc., a biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases. The company’s lead candidate... more
NASDAQ 04/29/2025 4:00PM Eastern Quotes delayed